Table 4.
Multiple regression models of the relationship between the effect of serum levels of S-100 protein and BDNF on the effect of interventions on the SICI and CSP (n = 17).
| Dependent variable | Type III sum of squares | df | Mean square | F | P | Partial eta squared |
|---|---|---|---|---|---|---|
| Short intracortical inhibition (SICI) | 0.46 | 4 | 0.12 | 1.77 | 0.17 | 0.22 |
| Cortical silent period (CSP) | 3881.54 | 4 | 970.38 | 4.77 | 0.005 | 0.43 |
| B | Std. error | t | P | CI 95% | ||
| Dependent variable: short intracortical inhibition (SICI) | ||||||
| Intercept | 0.75 | 0.22 | 3.32 | 0.00 | (0.29 to 1.21) | |
| Serum S100-B protein | 0.01 | 0.022 | 0.63 | 0.53 | (−0.03 to 0.06) | |
| BDNF adjusted index | −0.02 | 0.011 | −1.78 | 0.09 | (−0.04 to 0.003) | |
| Interaction | ||||||
| Serum S100-B protein∗ treatment | −0.05 | 0.012 | −0.36 | 0.71 | (−0.06 to 0.02) | |
| BDNF adjusted index ∗ treatment | 0.06 | 0.006 | 1.01 | 0.32 | (−0.08 to 0.02) | |
| Dependent variable: cortical silent period (CSP) | ||||||
| Intercept | 62.12 | 12.61 | 4.93 | 0.00 | (36.15 to 88.09) | |
| Serum S100-B protein | −2.68 | 1.24 | −2.16 | 0.04 | (−5.24 to −0.12)∗∗ | |
| BDNF adjusted index | 1.41 | 0.601 | 2.33 | 0.02 | (0.16 to 2.65)∗∗ | |
| Interaction | ||||||
| Serum S100-B protein∗ treatment | 0.84 | 0.69 | 1.22 | 0.23 | (−0.57 to 2.25) | |
| BDNF adjusted index ∗ treatment | −0.43 | 0.31 | −1.38 | 0.18 | (−1.08 to 0.21) | |
∗∗Interaction between dependent variable (S100B or BDNF)*trearment (factor).